secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2022-01-07T23:59:59+00:00
Accession:  0001104659-22-002269
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics CFO Joseph Vazzano resigns; CEO Lucy Lu appointed interim CFO
--------------------------------------------------------------------------------

- Joseph Vazzano resigns as CFO effective Jan 14, 2022, to pursue other opportunities; no disagreement with company.
- Vazzano will transition to a consulting role under a consulting agreement dated Jan 7, 2022.
- Board appoints Dr. Lucy Lu, current President and CEO, as interim CFO and Principal Financial Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465922002269/0001104659-22-002269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465922002269/tm221800d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-002269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer